Proteomics International Laboratories Limited
ASX: PIQ.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jacqueline Gray
- Employees
- 37
- Headquarters
- Perth, Australia
- IPO year
- 2015
- Market cap
- A$28.9M
- Website
- https://www.proteomics.com.au
Loading PIQ…
Loading profile data…Frequently asked questions about PIQ
What does Proteomics International Laboratories Limited (PIQ.AX) do?
Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. Pro...
Where does PIQ.AX trade?
Proteomics International Laboratories Limited (PIQ.AX) trades on the Australian Securities Exchange.
What sector is PIQ.AX in?
Proteomics International Laboratories Limited (PIQ.AX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Proteomics International Laboratories Limited?
Jacqueline Gray is the chief executive officer of Proteomics International Laboratories Limited (PIQ.AX).
Where is Proteomics International Laboratories Limited headquartered?
Proteomics International Laboratories Limited is headquartered in Australia.
Does PIQ.AX pay a dividend?
Proteomics International Laboratories Limited (PIQ.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PIQ.AX go public?
Proteomics International Laboratories Limited (PIQ.AX) completed its initial public offering in 2015.